Syngene Intl. Reports Mixed Financial Results for Q2 FY25, Strong Operating Cash Flow a Highlight

Oct 23 2024 07:30 PM IST
share
Share Via
Syngene International has announced its financial results for the quarter ending September 2024, with a flat performance and a slight improvement in its score. The company's strong operating cash flow and increase in interest cost are key highlights and concerns, respectively. Investors are advised to hold their position and monitor future reports.

Syngene International, a leading pharmaceutical and drug company, has recently announced its financial results for the quarter ending September 2024. The company’s stock has been given a ‘Hold’ call by MarketsMOJO.

According to the financial report, Syngene Intl. has shown a flat performance in the quarter, with a slight improvement in its score from -11 to -2 in the last three months. However, the company has some positive aspects to its financials.


One of the key highlights is the company’s strong operating cash flow, which has been consistently growing over the past three years and is currently at its highest at Rs 1,042.10 Cr. This indicates that the company has been able to generate higher cash revenues from its business operations.


On the other hand, there are some areas that need improvement for Syngene Intl. The company’s Profit After Tax (PAT) for the quarter has fallen by -11.0% compared to the average PAT of the previous four quarters. This is a concerning trend in the near term.


Another red flag in the financial report is the increase in interest cost, which has risen by 11.97% (QoQ) and is currently at its highest in the last five quarters. This suggests that the company has taken on more borrowings, which could impact its financial stability.


Overall, Syngene International’s financial performance for the quarter ending September 2024 has been mixed. While the company has shown some positive aspects, there are also areas that need improvement. Investors are advised to hold their position and monitor the company’s future financial reports closely.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News